 |
| Lori Moore |
Germany's Bayer has brought on Lori Moore as VP & head of pharmaceutical communications in the US.
Moore moves to Bayer from Deloitte, where she most recently served as managing director, leading the company’s efforts to transform its internal communications.
Prior to joining Deloitte, she held communications leadership positions at Novo Nordisk and Sanofi.
At Bayer, Moore will be responsible for developing and executing external and internal communication strategies for the company’s pharmaceutical portfolio in the U.S., with a specific emphasis on cardiology, oncology, women’s health, hematology and radiology.
“Her impressive knowledge and expertise will help us advance our communications about the company’s pharmaceutical business here in this country,” said Ray Kerins, Bayer senior VP of corporate affairs.
The future of DTC should foster understanding and trust, as well as improving clinical conversations.
Healing the Sick Care System: Why People Matter, a new book from FINN Partners chair global health and purpose Gil Bashe, says that the current healthcare system is not broken because it lacks innovation, talent or investment, but because it has lost sight of the people it exists to serve.
Jeff Smokler, former president at healthcare specialist imre, joins Washington-based Avoq to head its PA practice.
